Probiotic VSL#3 Treatment Reduces Colonic Permeability and Abdominal Pain Symptoms in Patients With Irritable Bowel Syndrome

Simple item page
dc.contributor.authorPrapaporn Boonma
dc.contributor.authorJordan Shapiro
dc.contributor.authorEmily B. Hollister
dc.contributor.authorShyam Badu
dc.contributor.authorQinglong Wu
dc.contributor.authorErica M. Weidler
dc.contributor.authorBincy Abraham
dc.contributor.authorSridevi Devaraj
dc.contributor.authorRuth Ann Luna
dc.contributor.authorJames Versalovic
dc.contributor.authorMargaret Heitkemper
dc.contributor.authorTor Savidge
dc.contributor.authorRobert J. Shulman
dc.date.accessioned2026-05-08T19:15:42Z
dc.date.issued2021-9-22
dc.description.abstractwww.clinicaltrials.gov, Identifier: NCT00971711.
dc.identifier.doi10.3389/fpain.2021.691689
dc.identifier.urihttps://dspace.kmitl.ac.th/handle/123456789/15173
dc.publisherFrontiers in Pain Research
dc.subjectGastrointestinal motility and disorders
dc.subjectGut microbiota and health
dc.subjectProbiotics and Fermented Foods
dc.titleProbiotic VSL#3 Treatment Reduces Colonic Permeability and Abdominal Pain Symptoms in Patients With Irritable Bowel Syndrome
dc.typeArticle

Files

Collections

All